PRESS RELEASE
News
-
-
PRESS RELEASE
Crofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational New Animal Drug Application for the Indication of General Diarrhea in Dogs
Jaguar Health, Inc. establishes Investigational New Animal Drug (INAD) file with FDA for crofelemer to treat canine diarrhea. Conditional approval received for chemotherapy-induced diarrhea (CID) in dogs -
PRESS RELEASE
Pathfinder Announces Expansion into Eastern Canada with Agreement to Manage 5 RV Parks; Pathfinder also Secures Right of First Refusal on 5 Individual RV Park Assets
Pathfinder Ventures Inc. secures Right of First Refusal for 5 RV resorts in Eastern Canada and enters management agreement for 5 RV resorts, aiming for strategic growth in Ontario and Nova Scotia -
PRESS RELEASE
EQS-Adhoc: Allgeier SE: Transformation to higher gross margins characterizes the first quarter of 2024
Allgeier SE reports stable gross profit of EUR 39 million and a higher gross margin of 33.7% in Q1 2024, showing a transformation towards higher margins. Full-year 2024 outlook in line with guidance -
-
-
PRESS RELEASE
Point de situation - METEX NØØVISTAGO : Prorogation de la date limite de dépôt des offres de reprise
METEX NØØVISTAGO proroge la date limite de dépôt des offres de reprise suite au redressement judiciaire de sa filiale. Le groupe Avril étudie un projet de reprise avec des partenaires publics -
PRESS RELEASE
Rockhaven Announces Improved Metallurgical Test Work Results on its Klaza Project, Yukon
Rockhaven Resources Ltd. (TSXV:RK) announces optimized flowsheet testing results at Klaza property, showing potential to reduce costs and improve efficiencies in mineral processing. CEO discusses benefits of new processing techniques -
PRESS RELEASE
Aurubis: Steffen Alexander Hoffmann appointed new Chief Financial Officer at Aurubis AG
Steffen Alexander Hoffmann appointed as new Chief Financial Officer at Aurubis AG, effective October 1, 2024, for a 3-year term. Supervisory Board cites international finance experience as key to growth strategy implementation -
PRESS RELEASE
Inspire Veterinary Partners Announces 1-for-100 Reverse Stock Split
Inspire Veterinary Partners, Inc. announces 1-for-100 reverse stock split effective May 8, 2024, to comply with Nasdaq's minimum bid price. The Company's Common Stock will trade under symbol 'IVP' on a split-adjusted basis
